about
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...
Read More
1108.09
44.05
(4.14%)
4.6M
XNYS Volume
XNYS 07 Jan, 2026 4:30 PM (EST)
Acquisition Talks
Lilly is reportedly in talks to buy Ventyx Biosciences for $1 bn to expand its immunology segment
See details
High Financial Strength
Expensive Valuation
Technically Moderately Bullish
Expensive Star
These stocks are bullish, strong in quality and technicals, but expensive in valuation. Investors need to be cautious
View Similar
Embed DVM
Eli Lilly Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..